Genomics implicates adaptive and innate immunity in Alzheimer's and Parkinson's diseases

Annals of Clinical and Translational Neurology

Volumn 3, Issue 12, 2016, Pages 924-933

  Gagliano, Sarah A ^a,b,c   Pouget, Jennie G ^b,c,d   Hardy, John ^e   Knight, Jo ^b,c,d,f   Barnes, Michael R ^g   Ryten, Mina ^e   Weale, Michael E ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f LANCASTER UNIVERSITY   (United Kingdom)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD15 ANTIGEN; CD20 ANTIGEN; CD34 ANTIGEN; CD40 ANTIGEN; DEOXYRIBONUCLEASE I; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 8; PHOSPHATIDYLINOSITOL 3 KINASE;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL MATURATION; CONTROLLED STUDY; FUNCTIONAL GENOMICS; GENE ACTIVATION; HERITABILITY; HUMAN; INNATE IMMUNITY; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; PARKINSON DISEASE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 85026632960     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/acn3.369     Document Type: Article

References (55)

1. Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013;45:1452–1458.
2. Fogh I, Ratti A, Gellera C, et al. A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum Mol Genet 2014;23:2220–2231.
3. Nalls MA, Pankratz N, Lill CM, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet 2014;46:989–993.
4. Maurano MT, Haugen E, Sandstrom R, et al. Large-scale identification of sequence variants influencing human transcription factor occupancy in vivo. Nat Genet 2015;47:1393–1401.
5. Farh KK-H, Marson A, Zhu J, et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 2015;518:337–343.
6. Gagliano SA, Barnes MR, Weale ME, Knight J. A Bayesian method to incorporate hundreds of functional characteristics with association evidence to improve variant prioritization. PLoS One 2014;9:e98122.
7. Schaub MA, Boyle AP, Kundaje A, et al. Linking disease associations with regulatory information in the human genome. Genome Res 2012;22:1748–1759.
8. The GTEx Consortium. The genotype-tissue expression (GTEx) project. Nat Genet 2013;45:580–585.
9. Ardlie KG, Deluca DS, Segrè AV, et al. The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 2015;348:648–660.
10. Ramasamy A, Trabzuni D, Guelfi S, et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci 2014;17:1418–1428.
11. Akbarian S, Liu C, Knowles JA, et al. The PsychENCODE project. Nat Neurosci 2015;18:1707–1712.
12. Miller JA, Ding S-L, Sunkin SM, et al. Transcriptional landscape of the prenatal human brain. Nature 2014;508:199–206.
13. Fromer M, Roussos P, Sieberts SK, et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. bioRxiv 2016; doi: http://dx.doi.org/10.1101/052209.
14. Roadmap Epigenomics Consortium, Kundaje A, Meuleman W, et al. Integrative analysis of 111 reference human epigenomes. Nature 2015;518:317–330.
15. Floyd RA. Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radic Biol Med 1999;26:1346–1355.
16. Klegeris A, McGeer EG, McGeer PL. Therapeutic approaches to inflammation in neurodegenerative disease. Curr Opin Neurol 2007;20:351–357.
17. Steinman L. Multiple sclerosis: a two-stage disease. Nat Immunol 2001;2:762–764.
18. International Multiple Sclerosis Genetics Consortium. Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls. Am J Hum Genet 2013;92:854–865.
19. van Baarsen LGM, van der Pouw Kraan TCTM, Kragt JJ, et al. A subtype of multiple sclerosis defined by an activated immune defense program. Genes Immun 2006;7:522–531.
20. Hellings N, Gelin G, Medaer R, et al. Longitudinal study of antimyelin T-cell reactivity in relapsing–remitting multiple sclerosis: association with clinical and MRI activity. J Neuroimmunol 2002;126:143–160.
21. Hernandez-Pedro NY, Espinosa-Ramirez G, Perez de la Cruz V, et al. Initial immunopathogenesis of multiple sclerosis: innate immune response. J Immunol Res 2013;2013:e413465.
22. Yokoyama JS, Wang Y, Schork AJ, et al. Association between genetic traits for immune-mediated diseases and Alzheimer disease. JAMA Neurol 2016;73:691–697.
23. Jones L, Holmans PA, Hamshere ML, et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One 2010;5:e13950.
24. International Genomics of Alzheimer's Disease Consortium (IGAP). Convergent genetic and expression data implicate immunity in Alzheimer's disease. Alzheimers Dement 2015;11:658–671.
25. Wang Y, Cella M, Mallinson K, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell 2015;160:1061–1071.
26. Holmans P, Moskvina V, Jones L, et al. A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease. Hum Mol Genet 2013;22:1039–1049.
27. Durrenberger PF, Grünblatt E, Fernando FS, et al. Inflammatory pathways in Parkinson's disease. A BNE microarray study. Parkinsons Dis 2012;2012:214714.
28. Kannarkat GT, Boss JM, Tansey MG. The role of innate and adaptive immunity in Parkinson's disease. J Parkinsons Dis 2013;3:493–514.
29. Hamza TH, Zabetian CP, Tenesa A, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 2010;42:781–785.
30. McCombe P, Henderson R. The role of immune and inflammatory mechanisms in ALS. Curr Mol Med 2011;11:246–254.
31. Finucane HK, Bulik-Sullivan B, Gusev A, et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat Genet 2015;47:1228–1235.
32. Pouget JG, Gonçalves VF; Consortium SWG of the PG, et al. Genome-wide association studies suggest limited immune gene enrichment in schizophrenia compared to 5 autoimmune diseases. Schizophr Bull 2016;42:1176–1184.
33. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476:214–219.
34. Bulik-Sullivan B, Finucane HK, Anttila V, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet 2015;47:1236–1241.
35. Mifsud B, Tavares-Cadete F, Young AN, et al. Mapping long-range promoter contacts in human cells with high-resolution capture Hi-C. Nat Genet 2015;47:598–606.
36. Raychaudhuri S, Korn JM, McCarroll SA, et al. Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function. PLoS Genet 2010;6:e1001097.
37. Krämer A, Green J, Pollard J, Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 2014;30:523–530.
38. Chen EY, Tan CM, Kou Y, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 2013;14:128.
39. Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 2016;44:W90–W97.
40. Anttila V, Bulik-Sullivan B, Finucane HK, et al. Analysis of shared heritability in common disorders of the brain [Internet]. bioRxiv 2016. Available at: http://biorxiv.org/content/early/2016/04/16/048991.article-info doi: http://dx.doi.org/10.1101/048991.
41. Pugazhenthi S, Wang M, Pham S, et al. Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons. Mol Neurodegener 2011;6:60.
42. Wieduwilt MJ, Moasser MM. The epidermal growth factor receptor family: biology driving targeted therapeutics. Cell Mol Life Sci 2008;65:1566–1584.
43. Franks AL, Slansky JE. Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. Anticancer Res 2012;32:1119–1136.
44. Devine MJ, Plun-Favreau H, Wood NW. Parkinson's disease and cancer: two wars, one front. Nat Rev Cancer 2011;11:812–823.
45. Guerreiro R, Wojtas A, Bras J, et al. TREM2 variants in Alzheimer's disease. N Engl J Med 2013;368:117–127.
46. Jonsson T, Stefansson H, Steinberg S, et al. Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 2013;368:107–116.
47. Bilbo SD, Schwarz JM. The immune system and developmental programming of brain and behavior. Front Neuroendocrinol 2012;33:267–286.
48. Ransohoff RM, Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 2012;12:623–635.
49. Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels. Nature 2015;523:337–341.
50. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008;57:178–201.
51. Abel T, Zukin RS. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 2008;8:57–64.
52. Zelcer N, Khanlou N, Clare R, et al. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc Natl Acad Sci USA 2007;104:10601–10606.
53. Kang J, Rivest S. Lipid metabolism and neuroinflammation in Alzheimer's disease: a role for liver X receptors. Endocr Rev 2012;33:715–746.
54. Wen AY, Sakamoto KM, Miller LS. The role of the transcription factor CREB in immune function. J Immunol 2010;185:6413–6419.
55. Lacar B, Linker SB, Jaeger BN, et al. Nuclear RNA-seq of single neurons reveals molecular signatures of activation. Nat Commun 2016;7:11022.